Table 2

Patient demographics

DemographicPatients (n=185)
n (%)
Mean age, years (SD)56.0 (13.1)
Mean 6 min walk test, metres (SD)365 (146)*
Mean incremental shuttle walk test, metres (SD)298 (198)*
Gender
 Male59 (32)
 Female126 (68)
PH diagnosis
 Idiopathic PAH66 (36)
 CTEPH20 (11)
 CTD PAH32 (18)
 Congenital PAH35 (19)
 Familial PH2 (1)
 Other6 (3)
 Unsure21 (12)
Lives with
 Family140 (76)
 Alone30 (16)
 Friends3 (2)
 Other11 (6)
Employment
 Full time17 (9)
 Part time26 (14)
 Not employed61 (34)
 Retired77 (43)
WHO FC (patient reported)
 Class I8 (5)
 Class II60 (34)
 Class III75 (42)
 Class IV34 (19)
HADS-Anxiety score
 0–7360 (61)
 8–10108 (18)
 11–1489 (15)
 15–2132 (5)
HADS-Depression score
 0–7426 (73)
 8–10103 (18)
 11–1447 (8)
 15–2111 (2)
Oxygen
  Not at all111 (61)
  Night-time only19 (10)
  As I need it25 (14)
  All of the time27 (15)
Therapy
  Single70 (39)
  Dual92 (51)
  Triple11 (6)
  No treatment7 (4)
Nebuliser therapy
  No165 (93)
  Yes13 (7)
Subcutaneous therapy
  No173 (97)
  Yes5 (3)
Intravenous therapy
  No173 (97)
  Yes5 (3)
  • *Baseline values for the 6 min walk test and incremental shuttle walk test were missing in 31 and 10 patients, respectively.

  • CTD, connective tissue disease; CTEPH, chronic thromboembolic pulmonary hypertension; HADS, Hospital Anxiety and Depression Scale; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; WHO FC, WHO functional class.